Log in
Enquire now
Audentes Therapeutics

Audentes Therapeutics

Audentes Therapeutics is a San Francisco-based therapeutics and genetic medicines company.

OverviewStructured DataIssuesContributors

Contents

audentestx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Technology
Technology
Genealogy
Genealogy
‌
Genetic testing
Medical diagnostics
Medical diagnostics
Biopharmaceutical
Biopharmaceutical
RNA-based and RNA-targeted therapeutics
RNA-based and RNA-targeted therapeutics
...
Location
San Francisco
San Francisco
B2X
B2B2C
B2B2C
B2B
B2B
0
CEO
‌
Natalie Holles
Founder
‌
Matt Patterson
Pitchbook URL
pitchbook.com/profiles.../58017-70
Legal Name
Audentes Therapeutics, Inc.
Parent Organization
Astellas Venture Management
Astellas Venture Management
Legal classification
Incorporation (business)
Incorporation (business)
Date Incorporated
January 14, 2013
Number of Employees (Ranges)
201 – 500
Email Address
info@audentestx.com
Phone Number
+14158181001
+14156386556
Full Address
600 California Street, 17th Floor San Francisco, CA 94108
CIK Number
1,628,7380
Place of Incorporation
Delaware
Delaware
0
Investors
Redmile Group
Redmile Group
Sofinnova Investments
Sofinnova Investments
OrbiMed
OrbiMed
RA Capital Management
RA Capital Management
Rock Springs Capital
Rock Springs Capital
Versant Ventures
Versant Ventures
5AM Ventures
5AM Ventures
‌
Deerfield (company)
...
DUNS Number
0792533760
IRS Number
461,606,1740
Founded Date
2020
0
Total Funding Amount (USD)
137,499,951
Latest Funding Round Date
October 2015
Competitors
Dimension Therapeutics
Dimension Therapeutics
Voyager
Voyager
Amicus Therapeutics
Amicus Therapeutics
Bluebird Bio
Bluebird Bio
Valerion Therapeutics
Valerion Therapeutics
Sangamo Therapeutics
Sangamo Therapeutics
uniQure
uniQure
Spark Therapeutics
Spark Therapeutics
Business Model
Commerce
Glassdoor ID
1152419
Acquisition Transaction
‌
Acquisition of Audentes Therapeutics by Astellas
Latest Funding Type
Series A
Series A
CAGE Code
78BM80
Patents Assigned (Count)
1
Country
United States
United States

Other attributes

Acquirer
Astellas Pharma Us
Astellas Pharma Us
Company Operating Status
Active
SIC Code
2,8360

Audentes Therapeutics is a developer of genetic medicines and products targeting serious rare neuromuscular diseases.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Audentes Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.